Sigma Healthcare Ltd

As of June 30, 2026, Sigma Healthcare Ltd carries a market capitalization of 18.63B, placing it among publicly traded companies globally. Its enterprise value stands at 19.78B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Sigma Healthcare Ltd's next confirmed earnings release is scheduled for March 4, 2027.

As of June 30, 2026, Sigma Healthcare Ltd has 11.50B shares outstanding.

As of June 30, 2026, Sigma Healthcare Ltd trades at a trailing price-to-earnings ratio of 43.38. The price-to-sales ratio is 2.84, and the price-to-book ratio stands at 6.16.

As of June 30, 2026, Sigma Healthcare Ltd trades at an EV/EBITDA multiple of 32.91 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.01 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 35.99 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 19.78B versus a market cap of 18.63B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Sigma Healthcare Ltd maintains a current ratio of 1.67, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 40.50, indicating elevated leverage, while an interest coverage ratio of 21.37 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Sigma Healthcare Ltd posted a return on equity (ROE) of 14.67, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 9.02 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 8.25, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 10.81, useful for judging operating efficiency across full business cycles. Inventory turnover of 7.84 indicates how many times Sigma Healthcare Ltd sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Sigma Healthcare Ltd recorded 179.55M in income tax expense. That works out to an effective tax rate of 29.49, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 608.82M, leaving 429.58M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on September 2, 2026, Sigma Healthcare Ltd's stock has declined approximately 2.38% over the past 52 weeks. The 50-day moving average sits at 1.71, while the 200-day moving average is 1.67.

Over the twelve months ended June 30, 2026, Sigma Healthcare Ltd generated 6.56B in revenue and converted that into 429.58M in net income, yielding earnings per share of 0.04. EBITDA reached 600.93M, while operating income came in at 549.42M.

As of June 30, 2026, Sigma Healthcare Ltd holds 79.43M in cash and equivalents against 1.22B in total debt, resulting in a net debt position of 401.75M. Total book value stands at 3.03B, with working capital of 833.69M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Sigma Healthcare Ltd posted a gross margin of 18.06, reflecting its pricing power and cost economics. The operating margin of 8.37 and net profit margin of 6.55 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Sigma Healthcare Ltd paid dividends of 0.02 per share. The dividend payout ratio of 53.50 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 2.10, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Sigma Healthcare Ltd shareholders.

Sigma Healthcare Ltd's most recent stock split took place on December 13, 2023 with a 781:805 split ratio.

As of June 30, 2026, Sigma Healthcare Ltd has an Altman Z-Score of 7.94, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.